Science Explorer Back to mapMap
Discussion
Researcher · Institut Curie · France

Christophe Le Tourneau

Christophe Le Tourneau publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Otorhinolaryngology, on topics such as Head and Neck Cancer Studies, Cancer Genomics and Diagnostics and Lung Cancer Treatments and Mutations.

OpenAlex
World rank
#3,286,412
of 7,710,434 ranked researchers
Rank in France
#138,850
of 324,115
Works
79
Citations
708
Citations per work
9.0
h-index
13
i10-index 18Top 44% in Oncology
Christophe Le Tourneau

What does Christophe Le Tourneau research?

Christophe Le Tourneau's work is mostly in Medicine (51%), Biochemistry, Genetics and Molecular Biology (14%).

Health Sciences: 40 works · 51.2% of their workMedicine: 40 works · 51.2% of their workOncology: 17 works · 21.7% of their workPulmonary and Respiratory Medicine: 11 works · 13.8% of their workOtorhinolaryngology: 7 works · 9.2% of their workRadiology, Nuclear Medicine and Imaging: 5 works · 6.5% of their workEverything else: 28 works · 34.9% of their workLife Sciences: 11 works · 13.9% of their workBiochemistry, Genetics and Molecular Biology: 11 works · 13.9% of their workMolecular Biology: 6 works · 7.4% of their workCancer Research: 5 works · 6.5% of their workTHEIR WORKChristophe LeTourneau79works
Life Sciences14%Health Sciences51%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine4051.2%
  2. Everything else2834.9%
    1. Biochemistry, Genetics and Molecular Biology1113.9%
  1. 1Oncology22% of their works
  2. 2Pulmonary and Respiratory Medicine14% of their works
  3. 3Otorhinolaryngology9% of their works
  4. 4Molecular Biology7% of their works
  5. 5Cancer Research6% of their works
  6. 6Radiology, Nuclear Medicine and Imaging6% of their works

Research topics

Which keywords describe Christophe Le Tourneau's research?

The keywords of their largest research topics: Targeted Therapy, Chemotherapy, Cetuximab, Human Papillomavirus, Oropharyngeal Cancer, Clinical Trials, Biomarkers and Cancer Genomics.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Targeted Therapy354 topics
  2. Chemotherapy333 topics
  3. Cetuximab272 topics
  4. Human Papillomavirus201 topic
  5. Oropharyngeal Cancer201 topic
  6. Clinical Trials162 topics
  7. Biomarkers122 topics
  8. Cancer Genomics111 topic
  9. Mutational Signatures111 topic
  10. ALK Inhibitors101 topic
  11. EGFR Mutations101 topic
  12. Immune Checkpoint Blockade81 topic
  13. PD-1 and PD-L181 topic
  14. PET Imaging81 topic
  15. Radiopharmaceuticals81 topic
  16. Fluorouracil71 topic
  17. KRAS Mutations71 topic
  18. Adaptive Designs61 topic
  19. False Discovery Rate61 topic
  20. Genomic Profiles61 topic
  21. Small-Cell Lung Cancer61 topic

Where does Christophe Le Tourneau work?

Christophe Le Tourneau's main affiliation in the publication record is Institut Curie, France.

How many publications and citations does Christophe Le Tourneau have?

OpenAlex counts 79 works and 708 citations for Christophe Le Tourneau, an h-index of 13, ranking #3,286,412 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Christophe Le Tourneau

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Christophe Le Tourneau. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.